References
Miller MA, Kane M. Routine Hepatitis B Immunization in India: Cost effectiveness assessment.Indian J Pediatr 2000; 67: 299–300.
Adkins SB. Immunization: Current Recommendations.Am Family Physician 1997; 56: 865–874.
Beasley RP. Hepatitis B virus: The major etiology of hepatocellular carcinoma.Cancer 1988; 61:1942–1956.
McMohan BJ, Albert SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B related sequelae: prospective study in 1400 hepatitis B surface antigen positive Alaska carriers.Arch Intern Med 1990; 150:1051–1054.
Sakuma K, Saitosh N, Kasai M, Jitsukawa H, Yshino T, Yamaguchi Met al. Relative risk of death due to liver disease among Japanese male adults having various statuses of hepatitis B ‘S’ and ‘e’ antigen/antibody in serum: a prospective study.Hepatology 1988; 8:1642–1646.
Miller MA, McCann L. Policy analysis of the use of Hepatitis B, Hemophilus influenzae type B, Streptococcus pneumoniaeconjugate and Rotavirus vaccines in the National Immunization Schedules.Health Economics 2000; 9:19–35.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Puliyel, J.M., Mittal, R., Tyagi, V. et al. Routine Hepatitis B immunization in India : Cost effectiveness needs reassessment. Indian J Pediatr 70, 188 (2003). https://doi.org/10.1007/BF02723756
Issue Date:
DOI: https://doi.org/10.1007/BF02723756